|
| Index | - | P/E | - | EPS (ttm) | -0.87 | Insider Own | 37.00% | Shs Outstand | 27.30M | Perf Week | -3.67% |
| Market Cap | 1.43B | Forward P/E | - | EPS next Y | -0.40 | Insider Trans | 8.29% | Shs Float | 13.83M | Perf Month | -1.44% |
| Income | -12.90M | PEG | - | EPS next Q | -0.22 | Inst Own | 51.70% | Short Float | 8.92% | Perf Quarter | -21.35% |
| Sales | 26.90M | P/S | 53.03 | EPS this Y | -12.50% | Inst Trans | 2.18% | Short Ratio | 5.04 | Perf Half Y | - |
| Book/sh | 10.73 | P/B | 4.86 | EPS next Y | 25.90% | ROA | - | Target Price | 67.50 | Perf Year | - |
| Cash/sh | 5.82 | P/C | 8.96 | EPS next 5Y | - | ROE | - | 52W Range | 38.88 - 79.60 | Perf YTD | -8.41% |
| Dividend | - | P/FCF | 347.95 | EPS past 5Y | - | ROI | -3.80% | 52W High | -34.47% | Beta | - |
| Dividend % | - | Quick Ratio | 15.40 | Sales past 5Y | - | Gross Margin | 55.50% | 52W Low | 34.16% | ATR | 2.98 |
| Employees | 101 | Current Ratio | 15.80 | Sales Q/Q | 67.60% | Oper. Margin | -22.00% | RSI (14) | 50.15 | Volatility | 5.25% 5.64% |
| Optionable | No | Debt/Eq | 0.11 | EPS Q/Q | -426.20% | Profit Margin | -48.00% | Rel Volume | 0.92 | Prev Close | 51.90 |
| Shortable | Yes | LT Debt/Eq | 0.10 | Earnings | May 13 BMO | Payout | - | Avg Volume | 244.46K | Price | 52.16 |
| Recom | 1.20 | SMA20 | 0.11% | SMA50 | 2.39% | SMA200 | -6.91% | Volume | 285,681 | Change | 0.50% |
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite